Danaher Corp. will pay about $2.2 billion for Nobel Biocare Holding AG. The deal is expected to widen Danaher’s market presence in the global dental industry.
Headquartered in Zurich, Switzerland, Nobel Biocare develops implant-based dental restorations and currently serves customers in 80 markets globally. The company’s portfolio of solutions includes dental implant systems, high-precision individualized prosthetics, biomaterials, and digital diagnostics, treatment planning, and guided surgery.
Henk van Duijnhoven, Senior Vice President of Danaher’s Dental segment, says, “Nobel Biocare has a very strong track record as an innovator and leader in the attractive market for dental implant and prosthetic solutions. Bringing Nobel Biocare’s deep expertise in implant dentistry, digital prosthetics and software together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize clinical workflows to the benefit of patients and dental practitioners. This combination will help us build a strong platform for future growth.”
Danaher’s President and CEO, Thomas P. Joyce, Jr., says, “Nobel Biocare’s broad reach and leadership position make it one of the strongest global brands in the dental industry today. We believe that application of the Danaher Business System will provide Nobel Biocare with a unique opportunity to further accelerate growth, expand margins, strengthen its market presence and develop innovative solutions for dental patients and practitioners around the world.”
Release Date: September 15, 2014